降血糖药物市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00024470
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

市场概览 糖尿病是一种因身体无法产生所需量的胰岛素而引起的代谢紊乱。糖尿病分为两种类型;胰岛素依赖性糖尿病(1 型)和非胰岛素依赖性糖尿病(2 型)。这些用于治疗2型糖尿病的药物被称为降血糖药物,用于对饮食、减肥和运动没有反应的患者。糖尿病的各种症状包括尿频、口渴、饥饿和伤口愈合延迟。 市场范围 “到2031年全球降血糖药物市场分析”是对医疗保健行业的专业深入研究,特别关注全球市场趋势分析。该报告旨在概述降血糖药物市场,并按类型、应用和地理位置进行详细的市场细分。该报告提供了主要降血糖药物市场参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。 市场细分
    • 根据类型,全球降血糖药物市场分为胰岛素、DPP-4、GLP-1、SGLT-2等。 • 根据应用,市场分为1型糖尿病和2型糖尿病。
市场动态 驱动因素:
    • 糖尿病发病率上升导致糖尿病护理需求增加以及人口老龄化加剧是驱动低血糖的因素全球药品市场。 • 久坐生活方式引起的疾病(例如肥胖)的日益流行以及不健康饮食消费的增加推动了市场的增长。 • 主要制药公司和政府组织为开发新产品而对研发活动的投资不断增加,推动了市场增长。 • 技术进步、医疗报销以及强大的抗糖尿病药物产品线的存在也有利于市场的增长。
限制:
    • 对可治疗与糖尿病共存的多种慢性疾病(如心血管疾病、高血压等)的抗糖尿病药物的巨大未满足的医疗需求。 • 减少药物疗效在一段时间内可能会导致其他健康并发症。 • 药品成本高。
该报告提供了该行业的详细概述,包括定性和定量信息。它提供了基于各个细分市场的全球市场的概述和预测。它还提供了 2021 年至 2031 年五个主要地区的市场规模和预测估计,即:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美洲。每个地区的降血糖药物市场随后按各自的国家和细分市场进行细分。该报告涵盖了全球18个国家以及该地区当前趋势和机遇的分析和预测。报告从需求和供给两个方面分析了影响市场的因素,并进一步评估了预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还为所有五个地区提供了详尽的 PEST 分析,即:评估了影响北美、欧洲、亚太地区、中东和非洲和南美地区降血糖药物市场的政治、经济、社会和技术因素后。 COVID-19 对降血糖药物市场的影响COVID-19 于 2021 年 12 月首次在中国武汉爆发,此后在全球范围内快速传播。从确诊病例和死亡人数来看,美国、印度、巴西、俄罗斯、法国、英国、土耳其、意大利和西班牙是受影响最严重的国家。由于封锁、旅行禁令和企业关闭,COVID-19 一直在影响各国的经济和行业。各种工厂、工厂的停工影响了全球供应链,也影响了全球整体市场。制药行业更专注于COVID-19疫苗的开发;因此,降血糖药物的研发工作大幅下降。虽然降糖药的需求不受影响;而且仍与 COVID-19 危机之前一样高。因此,市场将在预测期内大幅增长。 市场参与者 该报告涵盖了降血糖药物市场的主要发展,如有机和无机增长战略。许多公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上出现的无机增长战略活动包括收购、伙伴关系和合作。这些活动为市场参与者扩大业务和客户群铺平了道路。随着全球市场对降糖药物的需求不断增长,预计降糖药物市场的市场参与者未来将拥有利润丰厚的增长机会。该报告还包括主要公司的概况及其在降血糖药物市场的 SWOT 分析和市场策略。此外,该报告重点关注领先的行业参与者,提供公司简介、所提供的组件和服务、过去三年的财务信息、过去五年的关键发展等信息。
    • 赛诺菲 • 默克公司 • 诺和诺德 • 武田制药 • 礼来公司 • 辉瑞 • 勃林格殷格翰 • 诺华 • 强生公司 • 强生公司;阿斯利康
Insight 合作伙伴的专门研究和分析团队由经验丰富的专业人员组成,具有先进的统计专业知识,并在现有研究中提供各种定制选项。
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are some of the major players operating in the market?

Ecolab Inc., Cantel Medical, STERIS plc, 3M, MMM Group Limited, Getinge AB
Halyard Worldwide accounting for higesh market shares and are some of the major players operating in the market

Which segment accounts for highest revenue in product type the hypoglycemic drugs market in 2023?

The Sterilization Products
segment accounts for highest revenue in product the hypoglycemic drugs market in 2023

Which region higesh CAGR the hypoglycemic drugs market in 2023?

Asia Pacific region dominated the hypoglycemic drugs market in 2023

Which region dominated the hypoglycemic drugs market in 2023?

North America region dominated the hypoglycemic drugs market in 2023

What is the expected CAGR of the Hypoglycemic Drugs Market ?

The Hypoglycemic Drugs Market is estimated to witness a CAGR of 8.50% from 2023 to 2031

What are the driving factors impacting the hypoglycemic drugs market?

The major factors driving the hypoglycemic drugs market are:

1.Increasing Incidence of Infectious Diseases

2. Technological Advancements

3. Awareness and Training

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Sanofi
2. Merck and Co.
3. Novo Nordisk
4. Takeda Pharmaceuticals
5. Eli Lilly
6. Pfizer
7. Boehringer Ingelheim
8. Novartis
9. Johnson and Johnson
10. AstraZeneca

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.